De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Aster DM Healthcare Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Aster DM Healthcare heeft een totaal eigen vermogen van ₹50.3B en een totale schuld van ₹13.8B, wat de schuld-eigenvermogensverhouding op 27.5% brengt. De totale activa en totale passiva bedragen respectievelijk ₹179.9B en ₹129.6B. De EBIT Aster DM Healthcare is ₹3.9B waardoor de rentedekking 3.4 is. Het heeft contanten en kortetermijnbeleggingen van ₹1.2B.

Belangrijke informatie

27.5%

Verhouding schuld/eigen vermogen

₹13.84b

Schuld

Rente dekkingsratio	3.4x
Contant	₹1.16b
Aandelen	₹50.30b
Totaal verplichtingen	₹129.61b
Totaal activa	₹179.91b

Recente financiële gezondheidsupdates

Recent updates

Aster DM Healthcare Limited's (NSE:ASTERDM) Popularity With Investors Is Under Threat From Overpricing

Jul 20

Capital Allocation Trends At Aster DM Healthcare (NSE:ASTERDM) Aren't Ideal

Jun 23

Aster DM Healthcare (NSE:ASTERDM) Takes On Some Risk With Its Use Of Debt

May 30

With Aster DM Healthcare Limited (NSE:ASTERDM) It Looks Like You'll Get What You Pay For

Apr 14

Aster DM Healthcare Limited (NSE:ASTERDM) Shares Could Be 39% Below Their Intrinsic Value Estimate

Mar 27

Earnings Beat: Aster DM Healthcare Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Feb 12

Here's Why Aster DM Healthcare (NSE:ASTERDM) Can Manage Its Debt Responsibly

Feb 07

There's Been No Shortage Of Growth Recently For Aster DM Healthcare's (NSE:ASTERDM) Returns On Capital

Jan 19

Is Now An Opportune Moment To Examine Aster DM Healthcare Limited (NSE:ASTERDM)?

Apr 03

Is Aster DM Healthcare Limited (NSE:ASTERDM) Trading At A 42% Discount?

Mar 02

Should You Investigate Aster DM Healthcare Limited (NSE:ASTERDM) At ₹186?

Dec 17

Is Aster DM Healthcare (NSE:ASTERDM) A Risky Investment?

Dec 02

Is There An Opportunity With Aster DM Healthcare Limited's (NSE:ASTERDM) 29% Undervaluation?

Nov 19

There's Been No Shortage Of Growth Recently For Aster DM Healthcare's (NSE:ASTERDM) Returns On Capital

Nov 04

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( ₹141.7B ) ASTERDM } overtreffen de korte termijn passiva ( ₹112.9B ).

Langlopende schulden: De kortetermijnactiva ASTERDM ( ₹141.7B ) overtreffen de langetermijnschulden ( ₹16.7B ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 25.2% ) ASTERDM wordt als voldoende beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van ASTERDM is de afgelopen 5 jaar gedaald van 75.9% naar 27.5%.

Schuldendekking: De schuld van ASTERDM wordt niet goed gedekt door de operationele kasstroom ( 11.4% ).

Rentedekking: De rentebetalingen op de schuld van ASTERDM worden goed gedekt door EBIT ( 3.4 x dekking).

Aster DM Healthcare Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Aster DM Healthcare (NSE:ASTERDM) Takes On Some Risk With Its Use Of Debt

Here's Why Aster DM Healthcare (NSE:ASTERDM) Can Manage Its Debt Responsibly

Is Aster DM Healthcare (NSE:ASTERDM) A Risky Investment?

Recent updates

Aster DM Healthcare and Quality CARE Reportedly in Final Stages of Negotiations and Expects Deal to be Sign by the End of September 2024

Aster DM Healthcare Limited Announces Executive Changes

High number of new directors

Aster DM Healthcare Limited Approves Board Appointments

Upcoming dividend of ₹2.00 per share

Blackstone Reportedly in Talks with the Promoters of Aster DM Healthcare to Merge Quality Care India with Aster

First quarter 2025 earnings released: EPS: ₹1.49 (vs ₹0.10 in 1Q 2024)

Aster DM Healthcare Limited to Report Q1, 2025 Results on Jul 31, 2024

Aster DM Healthcare Limited's (NSE:ASTERDM) Popularity With Investors Is Under Threat From Overpricing

Capital Allocation Trends At Aster DM Healthcare (NSE:ASTERDM) Aren't Ideal

Olympus Capital Asia Investments to Sell Up to 10% Stake in Aster DM Healthcare through Block Deals

Consensus EPS estimates fall by 93%, revenue upgraded

Aster DM Healthcare Limited, Annual General Meeting, Aug 29, 2024

Price target decreased by 7.3% to ₹453

Aster Dm Healthcare Limited Proposes Final Dividend for the Financial Year 2023-24

Aster DM Healthcare (NSE:ASTERDM) Takes On Some Risk With Its Use Of Debt

Aster Dm Healthcare Limited Proposes Final Dividend for the Financial Year 2023-24

Full year 2024 earnings released: EPS: ₹2.46 (vs ₹8.54 in FY 2023)

Aster DM Healthcare Limited to Report Q4, 2024 Results on May 28, 2024

Aster DM Healthcare Limited Announces Resignation of Amitabh Johri as A Key Managerial Personnel

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 23%

Aster DM Healthcare Limited Declares Special Dividend

With Aster DM Healthcare Limited (NSE:ASTERDM) It Looks Like You'll Get What You Pay For

Aster DM Healthcare Limited Declares Special Dividend

Investor sentiment improves as stock rises 19%

Aster DM Healthcare Limited Announces Board Changes

Olympus Capital Reportedly Plans Stake Sale in Aster DM Healthcare

Aster DM Healthcare Limited (NSE:ASTERDM) Shares Could Be 39% Below Their Intrinsic Value Estimate

Price target increased by 9.3% to ₹459

Earnings Beat: Aster DM Healthcare Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

New major risk - Financial position

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Here's Why Aster DM Healthcare (NSE:ASTERDM) Can Manage Its Debt Responsibly

Aster DM Healthcare Limited to Report Q3, 2024 Results on Feb 08, 2024

There's Been No Shortage Of Growth Recently For Aster DM Healthcare's (NSE:ASTERDM) Returns On Capital

Now 20% undervalued

KKR, Ontario Teachers' Pension Plan and Care Hospitals Reportedly Submit Non-Binding Term Sheets to Acquire Stake in the Indian Business of Aster DM Healthcare

Aster DM Healthcare to Fuel India Expansion Through Buyouts

Now 20% undervalued

New minor risk - Share price stability

Consensus EPS estimates fall by 16%

Price target increased by 18% to ₹397

Investor sentiment improves as stock rises 17%

Second quarter 2024 earnings released: ₹0.62 loss per share (vs ₹0.93 profit in 2Q 2023)

Aster's India Unit Reportedly Draws Suitors Valuing Business At $1.5 Billion

New major risk - Financial position

Aster DM Healthcare Limited Announces Resignation Anoop Moopen as Non-Executive Director

Full year 2023 earnings: EPS misses analyst expectations

Aster DM Healthcare Limited to Report Q1, 2024 Results on Aug 14, 2023

Aster DM Healthcare Limited, Annual General Meeting, Aug 31, 2023

Aster Healthcare's Promoters Reportedly in Talks with Private Equity Groups, Look to Sell India Business

Aster DM Healthcare Confirms Talks with Fajr Capital, Others on Gulf Business

Investor sentiment improves as stock rises 16%

Consensus EPS estimates fall by 15%, revenue upgraded

Price target increased by 7.6% to ₹291

Aster Eye $300 million India Stake Sale

Full year 2023 earnings released: EPS: ₹8.54 (vs ₹10.58 in FY 2022)

Aster DM Healthcare Limited Announces Resignation of Sridar Arvamudhan Iyengar as Non-Executive Independent Director

Aster DM Healthcare Limited to Report Q4, 2023 Results on May 25, 2023

Third quarter 2023 earnings released: EPS: ₹2.80 (vs ₹2.98 in 3Q 2022)

Aster DM Healthcare Limited Appoints Rahul Kadavakolu as Group Chief Marketing Officer

Aster DM Healthcare Limited to Report Q3, 2023 Results on Feb 14, 2023

Aster DM Healthcare Limited Announces Resignation of Sreenath Pocha Reddy as Group Chief Financial Officer, Effective 5 January 2023

Consensus forecasts updated

Price target increased to ₹275

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Less than half of directors are independent

Aster DM Healthcare Limited Announces Retirement of Prof. Biju Varkkey as Non-Executive Independent Director

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Aster DM Healthcare Limited to Report Q2, 2023 Results on Nov 10, 2022

Aster DM Healthcare Limited (NSEI:ASTERDM) entered into share purchase agreement to acquire 22.69% stake in Sri SaiNatha Multi Speciality Hospitals Pvt. Ltd from promoters and their relatives for INR 250 million.